Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) Income from Continuing Operations (2019 - 2025)

Historic Income from Continuing Operations for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to -$9.7 million.

  • Strata Critical Medical's Income from Continuing Operations fell 7161.9% to -$9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.5 million, marking a year-over-year increase of 3566.06%. This contributed to the annual value of -$27.3 million for FY2024, which is 5130.36% up from last year.
  • Per Strata Critical Medical's latest filing, its Income from Continuing Operations stood at -$9.7 million for Q3 2025, which was down 7161.9% from -$3.7 million recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's Income from Continuing Operations peaked at $8.4 million during Q2 2022, and registered a low of -$33.9 million during Q4 2023.
  • In the last 5 years, Strata Critical Medical's Income from Continuing Operations had a median value of -$9.2 million in 2021 and averaged -$8.3 million.
  • Per our database at Business Quant, Strata Critical Medical's Income from Continuing Operations plummeted by 12980638.58% in 2021 and then soared by 20824.86% in 2022.
  • Strata Critical Medical's Income from Continuing Operations (Quarter) stood at $772000.0 in 2021, then crashed by 2096.76% to -$15.4 million in 2022, then plummeted by 120.18% to -$33.9 million in 2023, then surged by 45.27% to -$18.6 million in 2024, then surged by 48.01% to -$9.7 million in 2025.
  • Its Income from Continuing Operations was -$9.7 million in Q3 2025, compared to -$3.7 million in Q2 2025 and -$3.5 million in Q1 2025.